1374239-71-0

1374239-71-0 structure
1374239-71-0 structure
  • Name: BTK-IN-18
  • Chemical Name: BTK-IN-18
  • CAS Number: 1374239-71-0
  • Molecular Formula: C20H22Cl2N6O
  • Molecular Weight: 433.33
  • Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK Btk
  • Create Date: 2023-04-04 09:44:06
  • Modify Date: 2024-04-03 08:33:26
  • BTK-IN-18 is a potent, reversible BTK inhibitor with an IC50 of 0.002 µM. BTK-IN-18 inhibits both CD69 and CD86 in vivo[1].

Name BTK-IN-18
Description BTK-IN-18 is a potent, reversible BTK inhibitor with an IC50 of 0.002 µM. BTK-IN-18 inhibits both CD69 and CD86 in vivo[1].
Related Catalog
In Vivo BTK-IN-18 (化合物 41; 10, 25, 45 mg/kg; 腹腔给药; 单剂量) 对 CD69 和 CD86 产生强烈的剂量依赖性抑制[1]。 BTK-IN-18 (静脉给药; 1 mg/kg) 在大鼠中的 T1/2 为 5.3 小时,CL 为 19 mL/min/kg,Vss 为 1.3 L/kg[1]。 Animal Model: Mice[1] Dosage: 10, 25, 45 mg/kg Administration: IP; single dose Result: Caused robust dose-dependent inhibition of both CD69 and CD86 (74.8 %, 50.3 %, and 21.5 % respectively). Animal Model: Dosage: Administration: Result: Pharmacokinetic Parameters of BTK-IN-18 in rats[1]. IV (1 mg/kg) PO (5 mg/kg) Tmax (h) 1.6 Cmax (h∗mg/mL) 321 AUCinfi (h∗mg/mL) 1013 1421 t1/2 (ng/mL) 5.3 CL (mL/min/kg) 19 Vss (L/kg) 1.3 F (%) 23%
References

[1]. George H Vandeveer, et al. Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model. Bioorg Med Chem Lett. 2022 Dec 17;80:129108.  

Molecular Formula C20H22Cl2N6O
Molecular Weight 433.33
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.